TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $14,000 | -44.0% | 750 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $25,000 | -13.8% | 750 | 0.0% | 0.01% | -16.7% |
Q2 2021 | $29,000 | -19.4% | 750 | 0.0% | 0.01% | -25.0% |
Q1 2021 | $36,000 | -7.7% | 750 | 0.0% | 0.01% | -20.0% |
Q4 2020 | $39,000 | +95.0% | 750 | 0.0% | 0.01% | +66.7% |
Q3 2020 | $20,000 | +42.9% | 750 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $14,000 | +27.3% | 750 | -33.3% | 0.01% | +25.0% |
Q1 2020 | $11,000 | +37.5% | 1,124 | +49.9% | 0.00% | 0.0% |
Q4 2019 | $8,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |